Bibliographic information
Recommendation
Surgery for patients on MDR/RR-TB treatment: In patients with rifampicin-resistant tuberculosis (RR-TB) or multidrug-resistant TB (MDR-TB), elective partial lung resection (lobectomy or wedge resection) may be used alongside a recommended MDR-TB regimen.
Recommended in favor
Conditional
Certainty of evidence
Very low
Notes and Remarks
Subgroup considerations The relative benefits of surgery are expected to depend substantially on the population subgroups that are targeted. The analysis could not provide a refined differentiation of the type of patient who would be best suited to benefit from the intervention or the type of intervention that would have the most benefit. The effect is expected to be moderate in the average patient considered appropriate for surgery. The odds of success for patients with XDR-TB (pre-2021 definition) were statistically significantly lower when they underwent surgery compared with other patients (aOR: 0.4, 95% CL:
- 0.2–0.9). This effect is likely to be biased, given that patients who underwent surgery would have had other factors predisposing to poor outcomes that could not be adjusted for. Implementation considerations Partial lung resection for patients with MDR-TB is to be considered only under conditions of good surgical facilities and trained and experienced surgeons, and with careful selection of candidates.
Also Featured In
This recommendation also appears in the following guidelines:
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update
WHO guidelines on tuberculosis infection prevention and control: 2019 update
WHO consolidated guidelines on drug-resistant tuberculosis treatment
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update